MedPath

Early Amniotic Membrane Transplantation in Bacterial Keratitis

Not Applicable
Conditions
Keratitis of Both Eyes
Registration Number
NCT02716883
Lead Sponsor
Farabi Eye Hospital
Brief Summary

In this study Investigators are going to do early amniotic membrane transplantation (AMT) for bacterial keratitis.

Detailed Description

In this study investigators are going to do amniotic membrane transplantation (AMT), early in the first week for bacterial keratitis. Investigators are comparing this technique with no amniotic membrane transplantation (NAMT) in a clinical trial, Inform consent is going to be taken, then the enrolment population is added in the study. Investigators are going to compare the final scar size, the time to scar formation, perforation rate , early need to penetrating keratoplasty (PKP), risk of vision loss (being no light perception (NLP) between two groups.This trial has been approved by the review board in Tehran University of Medical Sciences.( 487/5671)

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
14
Inclusion Criteria

Bacterial keratitis being in the first week of diagnosis medically undergoing treatment

Exclusion Criteria

thinning limbal extension intraocular extension underlying disease Nocardia keratitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to scar formationIt needs at most 3 months

The time keratitis needs for scar to be formed

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.